GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Renhe Pharmacy Co Ltd (SZSE:000650) » Definitions » Debt-to-Revenue

Renhe Pharmacy Co (SZSE:000650) Debt-to-Revenue : 0.00 (As of Mar. 2025)


View and export this data going back to 1996. Start your Free Trial

What is Renhe Pharmacy Co Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Renhe Pharmacy Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2025 was ¥1 Mil. Renhe Pharmacy Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2025 was ¥2 Mil. Renhe Pharmacy Co's annualized Revenue for the quarter that ended in Mar. 2025 was ¥3,943 Mil. Renhe Pharmacy Co's annualized Debt-to-Revenue for the quarter that ended in Mar. 2025 was 0.00.


Renhe Pharmacy Co Debt-to-Revenue Historical Data

The historical data trend for Renhe Pharmacy Co's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Renhe Pharmacy Co Debt-to-Revenue Chart

Renhe Pharmacy Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.02 - - - -

Renhe Pharmacy Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Renhe Pharmacy Co's Debt-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Renhe Pharmacy Co's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Renhe Pharmacy Co's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Renhe Pharmacy Co's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Renhe Pharmacy Co's Debt-to-Revenue falls into.


;
;

Renhe Pharmacy Co Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Renhe Pharmacy Co's Debt-to-Revenue for the fiscal year that ended in Dec. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0.69 + 1.888) / 4074.893
=0.00

Renhe Pharmacy Co's annualized Debt-to-Revenue for the quarter that ended in Mar. 2025 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0.69 + 1.91) / 3942.58
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Mar. 2025) Revenue data.


Renhe Pharmacy Co Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Renhe Pharmacy Co's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Renhe Pharmacy Co Business Description

Traded in Other Exchanges
N/A
Address
No. 998, Honggutan Road, Greenland Central Plaza, 18th Floor, Yuanchuang International, Zone B, Honggutan New District, Jiangxi Province, Nanchang, CHN, 330038
Renhe Pharmacy Co Ltd is a China-based company engaged in the production and sale of Chinese and Western medicine, bulk drugs and health-related products. The products include oral solid preparations, oral liquid preparations, large-volume injections, small-volume injections, topical lotions, tinctures, suppositories, ointments and other pharmaceutical products and health-related products. The company's main products are Renhe Kelik, Youkadan series, Fu Yan Jie series, Dahuoluo capsules, shiny eye drops, Qinghuo capsules, Zhengwei capsules and others.
Executives
Yang Xiao Director
Kang Zhi Hua Supervisors
Mei Qiang Directors, executives
Yang Wen Long Director

Renhe Pharmacy Co Headlines

No Headlines